The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
A roundup of news from suppliers, contract development and manufacturing organizations (CDMOs), and contract manufacturing organizations (CMOs), featuring developments from Almac, Pii, PCI Pharma Services, MedPharm, and Thousand Oaks...
Boehringer Ingelheim has initiated a capacity expansion in its biopharmaceutical contract manufacturing business at its commercial manufacturing site for biologics in China. The expansion covers an additional bioreactor and includes all needed...
Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) of biologics and part of Fujifilm Corporation, plans to invest approximately JPY 10 billion (approximately $90 million) to expand existing production...
Catalent has announced an investment of $200 million in its biologics business to expand drug-substance manufacturing capacity and drug-product fill/finish capacity. The investments, phased over a three-year program, will be undertaken at the...
AGC Biologics, a contract manufacturer of biologics, has finalized plans to install 12 additional 2,000-liter single-use mammalian cell bioreactors and to establish a brand-new microbial contract development and manufacturing facility at its site...
Cambrex, a contract manufacturer of small-molecule active pharmaceutical ingredients and drug products, has completed its previously announced acquisition of Avista Pharma Solutions, a Durham, North Carolina-headquartered contract testing,...
A roundup of news from suppliers, contract development and manufacturing organizations, and contract manufacturing organizations, featuring news from Rentschler Biopharma, Pall, Recipharm, 3P Biopharmaceuticals, Fujifilm Irvine Scientific, and...
A roundup of the latest news from suppliers, contract development and manufacturing organizations, and contract manufacturing organizations, featuring Cambrex, WuXi AppTec, Lonza, and Roquette.
Chemicals/Chemical API Manufacturing
Cambrex...
A roundup of the latest news from suppliers, contract development and manufacturing organizations and contract manufacturing organizations, featuring Catalent Pharma Solutions and ABL.
Biologics manufacturing
ABL Expands Viral Vector...
AGC, a Tokyo-headquartered manufacturer of glass, chemicals, and specialty materials, has agreed to acquire Boehringer Ingelheim’s (BI’s) Malgrat Pharma Chemicals (MPC), a subsidiary of BI in Spain that manufactures intermediates and active...
A roundup of the latest news from suppliers, contract development and manufacturing organizations and contract manufacturing organizations, featuring Lonza, CordenPharma, Catalent Pharma Solutions, WuXi Biologics, PCI Pharma Services, and Kingchem...
A roundup of the latest news from suppliers, contract development and manufacturing organizations and contract manufacturing organizations, featuring Catalent Pharma Solutions, MilliporeSigma, Metrics Contract Services, Samsung Biologics, PMI...
A roundup of the latest news from suppliers, contract development and manufacturing organizations and contract manufacturing organizations, featuring WuXi Biologics and Recro Gainesville.
Biologics Manufacturing
WuXi Biologics Begins...
A roundup of the latest expansions and acquisition updates from suppliers, contract development and manufacturing organizations and contract manufacturing organizations, featuring news from Lubrizol, Lonza, and Thermo Fisher...
A roundup of the latest expansions and manufacturing updates from suppliers, contract development and manufacturing organizations and contract manufacturing organizations, featuring news from Recipharm, Hovione, Quotient Sciences, Jost Chemical,...
